HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


NIH Advisors Back Insuring Complementary, Alternative Solutions To Drugs For Health Care

This article was originally published in The Rose Sheet

Executive Summary

Consumers with chronic pain spend less in co-pays for pain medications than they would for natural remedies or treatments such as chiropractic or acupuncture because few insurance plans pay for alternative care, NIH advisory committee members say.

You may also be interested in...

Opioid Approval Standards Not Up For Debate, FDA Tells Advisory Cmte.

As Egalet's Arymo ER heads to panel, agency tries to head off discussion about whether it should be approving new opioid products and whether longer clinical efficacy trials should be demanded.

Can Insurers Curb Opioid Abuse? CDC Puts Spotlight On Payers

As Medicare emerges as the dominant payer for opioids, CDC urges research into how government and private payers could best employ prior authorization and drug utilization reviews.

Supplement Health Care Cost Savings Movement Faces Long Road

A CRN-funded report says specific supplement regimens could save the health care system billions, but the path to creating and funding dietary supplement programs for disease prevention is fraught with obstacles, including additional costs, political controversy and reticence to change by firms and insurers, experts say.


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts